Law360, New York (March 23, 2009, 12:00 AM EDT) -- Boston Scientific has agreed to settle all outstanding litigation with a New Jersey radiologist, putting to rest a three-year-long patent dispute over stent products. In connection with that settlement, the company expects to record a pretax charge to earnings of $50 million in the first quarter of 2009, it said.
(Corrects an article published on March 23.)
The settlement will dismiss Boston Scientific's appeal of a $501 million award in 2008 to Dr. Bruce Saffran, as well as a separate complaint filed by Saffran seeking additional...
Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.